Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2017 | 1 |
2019 | 3 |
2020 | 1 |
2022 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia.
Blood. 2019 Oct 3;134(14):1132-1143. doi: 10.1182/blood.2019000402. Epub 2019 Jul 10.
Blood. 2019.
PMID: 31292114
Free PMC article.
Review.
Gemtuzumab ozogamicin with fludarabine, cytarabine, and granulocyte colony stimulating factor (FLAG-GO) as front-line regimen in patients with core binding factor acute myelogenous leukemia.
Borthakur G, Cortes JE, Estey EE, Jabbour E, Faderl S, O'Brien S, Garcia-Manero G, Kadia TM, Wang X, Patel K, Luthra R, Koller C, Brandt M, Ravandi F, Kantarjian H.
Borthakur G, et al. Among authors: kadia tm.
Am J Hematol. 2014 Oct;89(10):964-8. doi: 10.1002/ajh.23795. Epub 2014 Jul 21.
Am J Hematol. 2014.
PMID: 24990142
Free PMC article.
Item in Clipboard
Which FLT3 Inhibitor for Treatment of AML?
Senapati J, Kadia TM.
Senapati J, et al. Among authors: kadia tm.
Curr Treat Options Oncol. 2022 Mar;23(3):359-380. doi: 10.1007/s11864-022-00952-6. Epub 2022 Mar 8.
Curr Treat Options Oncol. 2022.
PMID: 35258791
Review.
Item in Clipboard
Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review.
Boddu PC, Kadia TM.
Boddu PC, et al. Among authors: kadia tm.
Expert Rev Hematol. 2017 May;10(5):433-448. doi: 10.1080/17474086.2017.1313700. Epub 2017 Apr 28.
Expert Rev Hematol. 2017.
PMID: 28452257
Review.
Item in Clipboard
Myeloid cell leukemia-1 dependence in acute myeloid leukemia: a novel approach to patient therapy.
Kadia TM, Kantarjian HM, Konopleva M.
Kadia TM, et al.
Oncotarget. 2019 Feb 8;10(12):1250-1265. doi: 10.18632/oncotarget.26579. eCollection 2019 Feb 8.
Oncotarget. 2019.
PMID: 30815228
Free PMC article.
Review.
Item in Clipboard
The role of cladribine in acute myeloid leukemia: an old drug up to new tricks.
Molica M, Breccia M, Capria S, Trisolini S, Foa R, Jabbour E, Kadia TM.
Molica M, et al. Among authors: kadia tm.
Leuk Lymphoma. 2020 Mar;61(3):536-545. doi: 10.1080/10428194.2019.1672060. Epub 2019 Nov 22.
Leuk Lymphoma. 2020.
PMID: 31752577
Review.
Item in Clipboard
First-in-human study of JNJ-67571244, a CD33 × CD3 bispecific antibody, in relapsed/refractory acute myeloid leukemia and myelodysplastic syndrome.
Narayan R, Piérola AA, Donnellan WB, Yordi AM, Abdul-Hay M, Platzbecker U, Subklewe M, Kadia TM, Alonso-Domínguez JM, McCloskey J, Bradford K, Curtis M, Daskalakis N, Guttke C, Safer K, Hiebert B, Murphy J, Li X, Duchin K, Esteban D.
Narayan R, et al. Among authors: kadia tm.
Clin Transl Sci. 2024 Mar;17(3):e13742. doi: 10.1111/cts.13742.
Clin Transl Sci. 2024.
PMID: 38494922
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite